← FDA Drug Approvals (Drugs@FDA)

APIXABAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2019-12-23

Drug application

FDA Application #

ANDA210128

Application type

Abbreviated New Drug Application (Generic)

Brand name

APIXABAN

Generic name

Apixaban

Active ingredients

APIXABAN

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

MYLAN

First approval

2019-12-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown